iRhythm Technologies, Inc.

NasdaqGS:IRTC Stock Report

Market Cap: US$3.5b

iRhythm Technologies Future Growth

Future criteria checks 1/6

iRhythm Technologies is forecast to grow earnings and revenue by 64.4% and 14.1% per annum respectively. EPS is expected to grow by 65.8% per annum. Return on equity is forecast to be -5.5% in 3 years.

Key information

64.4%

Earnings growth rate

65.8%

EPS growth rate

Medical Equipment earnings growth16.2%
Revenue growth rate14.1%
Future return on equity-5.5%
Analyst coverage

Good

Last updated15 Apr 2024

Recent future growth updates

Here's What Analysts Are Forecasting For iRhythm Technologies, Inc. (NASDAQ:IRTC) After Its Annual Results

Feb 25
Here's What Analysts Are Forecasting For iRhythm Technologies, Inc. (NASDAQ:IRTC) After Its Annual Results

Recent updates

iRhythm Technologies, Inc.'s (NASDAQ:IRTC) Business Is Trailing The Industry But Its Shares Aren't

Mar 25
iRhythm Technologies, Inc.'s (NASDAQ:IRTC) Business Is Trailing The Industry But Its Shares Aren't

Here's What Analysts Are Forecasting For iRhythm Technologies, Inc. (NASDAQ:IRTC) After Its Annual Results

Feb 25
Here's What Analysts Are Forecasting For iRhythm Technologies, Inc. (NASDAQ:IRTC) After Its Annual Results

iRhythm Technologies (NASDAQ:IRTC) Has Debt But No Earnings; Should You Worry?

Feb 02
iRhythm Technologies (NASDAQ:IRTC) Has Debt But No Earnings; Should You Worry?

iRhythm Technologies, Inc. (NASDAQ:IRTC) Shares Could Be 30% Below Their Intrinsic Value Estimate

Dec 20
iRhythm Technologies, Inc. (NASDAQ:IRTC) Shares Could Be 30% Below Their Intrinsic Value Estimate

iRhythm Technologies, Inc. (NASDAQ:IRTC) Stocks Shoot Up 25% But Its P/S Still Looks Reasonable

Dec 20
iRhythm Technologies, Inc. (NASDAQ:IRTC) Stocks Shoot Up 25% But Its P/S Still Looks Reasonable

Is Now An Opportune Moment To Examine iRhythm Technologies, Inc. (NASDAQ:IRTC)?

Dec 02
Is Now An Opportune Moment To Examine iRhythm Technologies, Inc. (NASDAQ:IRTC)?

Health Check: How Prudently Does iRhythm Technologies (NASDAQ:IRTC) Use Debt?

Sep 20
Health Check: How Prudently Does iRhythm Technologies (NASDAQ:IRTC) Use Debt?

iRhythm Technologies, Inc. (NASDAQ:IRTC) Shares Could Be 25% Below Their Intrinsic Value Estimate

Aug 30
iRhythm Technologies, Inc. (NASDAQ:IRTC) Shares Could Be 25% Below Their Intrinsic Value Estimate

When Should You Buy iRhythm Technologies, Inc. (NASDAQ:IRTC)?

Jul 04
When Should You Buy iRhythm Technologies, Inc. (NASDAQ:IRTC)?

Is iRhythm Technologies (NASDAQ:IRTC) Using Debt In A Risky Way?

Jun 16
Is iRhythm Technologies (NASDAQ:IRTC) Using Debt In A Risky Way?

Estimating The Intrinsic Value Of iRhythm Technologies, Inc. (NASDAQ:IRTC)

May 26
Estimating The Intrinsic Value Of iRhythm Technologies, Inc. (NASDAQ:IRTC)

iRhythm Technologies, Inc.'s (NASDAQ:IRTC) P/S Is On The Mark

May 08
iRhythm Technologies, Inc.'s (NASDAQ:IRTC) P/S Is On The Mark

What Does iRhythm Technologies, Inc.'s (NASDAQ:IRTC) Share Price Indicate?

Mar 27
What Does iRhythm Technologies, Inc.'s (NASDAQ:IRTC) Share Price Indicate?

Is iRhythm Technologies (NASDAQ:IRTC) Using Debt Sensibly?

Feb 25
Is iRhythm Technologies (NASDAQ:IRTC) Using Debt Sensibly?

Health Check: How Prudently Does iRhythm Technologies (NASDAQ:IRTC) Use Debt?

Nov 24
Health Check: How Prudently Does iRhythm Technologies (NASDAQ:IRTC) Use Debt?

iRhythm falls after reaffirming 2022 guidance

Sep 21

iRhythm: Fairly Priced At Current Multiples, No Need To Size Up

Sep 02

Is iRhythm Technologies (NASDAQ:IRTC) Using Debt In A Risky Way?

Aug 18
Is iRhythm Technologies (NASDAQ:IRTC) Using Debt In A Risky Way?

iRhythm Technologies Q2 results beat estimates, co raises FY 2022 revenue guidance

Aug 04

iRhythm Technologies provides FY22 prelims, commercial chief resigns

Jul 19

iRhythm: Reimbursement Overhang Squashed, Bull Thesis Back Intact

Jun 08

Is iRhythm Technologies (NASDAQ:IRTC) A Risky Investment?

Apr 14
Is iRhythm Technologies (NASDAQ:IRTC) A Risky Investment?

Earnings and Revenue Growth Forecasts

NasdaqGS:IRTC - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2026808-5N/A1258
12/31/2025688-52166812
12/31/2024581-90-182312
12/31/2023493-123-91-50N/A
9/30/2023473-105-56-22N/A
6/30/2023452-99-50-19N/A
3/31/2023430-105-48-15N/A
12/31/2022411-116-53-23N/A
9/30/2022380-128-76-49N/A
6/30/2022362-131-69-35N/A
3/31/2022341-124-64-35N/A
12/31/2021323-101-66-38N/A
9/30/2021320-79-43-17N/A
6/30/2021306-59-42-24N/A
3/31/2021276-63-48-33N/A
12/31/2020265-44-27-14N/A
9/30/2020245-51-49-26N/A
6/30/2020228-65-59-38N/A
3/31/2020230-55-49-27N/A
12/31/2019215-55-42-22N/A
9/30/2019197-54-32-21N/A
6/30/2019181-45-34-26N/A
3/31/2019165-48-39-33N/A
12/31/2018147-50-34-29N/A
9/30/2018134-45-33-28N/A
6/30/2018120-42-31-27N/A
3/31/2018108-35-25-22N/A
12/31/201799-30-18-15N/A
9/30/201789-25N/A-12N/A
6/30/201781-22N/A-11N/A
3/31/201773-20N/A-14N/A
12/31/201664-21N/A-17N/A
9/30/201656-22N/A-21N/A
6/30/201649-24N/A-24N/A
3/31/201641-24N/A-24N/A
12/31/201536-23N/A-18N/A
9/30/201532-19N/A-17N/A
12/31/201422-16N/A-16N/A
12/31/201315-14N/A-12N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: IRTC is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: IRTC is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: IRTC is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: IRTC's revenue (14.1% per year) is forecast to grow faster than the US market (8.1% per year).

High Growth Revenue: IRTC's revenue (14.1% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: IRTC is forecast to be unprofitable in 3 years.


Discover growth companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.